News
The Howard County Board of Education is suing several Big Pharma companies for allegedly inflating insulin prices, affecting ...
Linear relationship seen for waist circumference, BP; reduction in HOMA-IR, hemoglobin A1c seen with modest weight reduction.
Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.
July kicks off the latter half of 2025, and the first six months of this year have been eventful, to say the least. Yet, the ...
Eli Lilly and Novo Nordisk, which already have approved GLP-1 weight loss drugs that are raking in billions of revenues, have ...
This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...
While Novo Nordisk stock has underperformed since my Strong Buy rating four months ago, the long-term investment thesis ...
CVS Caremark will stop covering Eli Lilly's Zepbound, a weight loss drug, due to insurance company changes. Patients are outraged and concerned.
Answering a random call was the serendipitous connection that led to Purdue Extension's new Downing Endowment for Community ...
The success of Vertex's opioid alternative Journavx could aid a group of biotechs that aim to take a similar path with NaV1.8 ...
1d
Zacks Investment Research on MSNHere is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending StockEli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results